Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trehalose hyaluronic acid versus sodium hyaluronate for knee osteoarthritis
ISRCTN18428696Phase 4Completed
- Sponsor
- OASI Bioresearch Foundation
- Start
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of trehalose hyaluronic acid and sodium hyaluronate in knee osteoarthritis (OA) (2 arms), sponsored by OASI Bioresearch Foundation. Primary endpoints: Treatment performance by KOOS, Treatment performance by IKDC and 1 more. Started Jun 2019; status: completed.
02
Drugs
trehalose hyaluronic acidsodium hyaluronate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ISRCTN18428696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN18428696.